📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants. (2022)

First Author: Hentzien M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fmicb.2022.998287

PubMed Identifier: 36312942

Publication URI: http://europepmc.org/abstract/MED/36312942

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in microbiology

ISSN: 1664-302X